UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Serum Haptoglobins in Megaloblastic Anaemia

British journal of haematology, 1960-07, Vol.6 (3), p.242-249

1960

Volltextzugriff (PDF)

MEASURING RISK AVERSION: ALLOCATION, LEVERAGE, AND ACCUMULATION

The Journal of financial research, 1991-04, Vol.14 (1), p.27-35

1991

Volltextzugriff (PDF)

Relative Risk Aversion Revisited

The review of economics and statistics, 1982-08, Vol.64 (3), p.481-487

1982

Volltextzugriff (PDF)

Investment in New Enterprise: Some Empirical Observations on Risk, Return, and Market Structure

Financial management, 1980-07, Vol.9 (2), p.44-51

1980

Volltextzugriff (PDF)

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

Journal of antimicrobial chemotherapy, 2013-05, Vol.68 Suppl 1 (suppl 1), p.i7-i22

2013

Volltextzugriff (PDF)

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

Blood, 2015-04, Vol.125 (17), p.2597-2604

2015

Volltextzugriff (PDF)

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

Antimicrobial Agents and Chemotherapy, 2011-05, Vol.55 (5), p.2434-2437

2011

Volltextzugriff (PDF)

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2554-2563

2014

Volltextzugriff (PDF)

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

Drugs (New York, N.Y.), 2018, Vol.78 (1), p.65-98

2018

Volltextzugriff (PDF)

Unbounded randomness certification using sequences of measurements

Physical review. A, 2017-02, Vol.95 (2), Article 020102

2017

Volltextzugriff (PDF)

A formalism for steering with local quantum measurements

New journal of physics, 2018-08, Vol.20 (8), p.83040

2018

Volltextzugriff (PDF)

On characterising assemblages in Einstein–Podolsky–Rosen scenarios

Journal of physics. A, Mathematical and theoretical, 2022-07, Vol.55 (26), p.264002

2022

Volltextzugriff (PDF)

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013)

Antimicrobial agents and chemotherapy, 2015-07, Vol.59 (7), p.4315-4317

2015

Volltextzugriff (PDF)

In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2992-2994

2011

Volltextzugriff (PDF)

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5707-5709

2013

Volltextzugriff (PDF)

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Antimicrobial Agents and Chemotherapy, 2009-08, Vol.53 (8), p.3280-3284

2009

Volltextzugriff (PDF)

Which breast pump for which mother: an evidence-based approach to individualizing breast pump technology

Journal of perinatology, 2016-07, Vol.36 (7), p.493-499

2016

Volltextzugriff (PDF)

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

Drugs (New York, N.Y.), 2013-02, Vol.73 (2), p.159-177

2013

Volltextzugriff (PDF)

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

Drugs (New York, N.Y.), 2014, Vol.74 (1), p.31-51

2014

Volltextzugriff (PDF)

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011

Clinical therapeutics, 2013-06, Vol.35 (6), p.872-877

2013

Volltextzugriff (PDF)

Crop genetic erosion: understanding and responding to loss of crop diversity

The New phytologist, 2022-01, Vol.233 (1), p.84-118

2022

Volltextzugriff (PDF)

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

Drugs (New York, N.Y.), 2015-02, Vol.75 (3), p.253-270

2015

Volltextzugriff (PDF)

Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia

Drugs (New York, N.Y.), 2016-12, Vol.76 (18), p.1737-1757

2016

Volltextzugriff (PDF)

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Antimicrobial Agents and Chemotherapy, 2008-04, Vol.52 (4), p.1430-1437

2008

Volltextzugriff (PDF)

Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008–2009)

Clinical microbiology and infection, 2012-03, Vol.18 (3), p.253-259

2012

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Englisch
(211)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(139)
Humans
(128)
Biological And Medical Sciences
(87)
Medical Sciences
(73)
Microbiology
(57)
Pharmacology & Pharmacy
(50)
Female
(49)
Infectious Diseases
(47)
Anti-Bacterial Agents - Pharmacology
(45)
Microbial Sensitivity Tests
(44)
Pharmacology. Drug Treatments
(38)
Male
(35)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(34)
Adult
(32)
Middle Aged
(25)
Drug Resistance, Bacterial
(23)
Escherichia Coli
(23)
Oncology
(22)
Aged
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum Haptoglobins in Megaloblastic Anaemia

MEASURING RISK AVERSION: ALLOCATION, LEVERAGE, AND ACCUMULATION

Relative Risk Aversion Revisited

Investment in New Enterprise: Some Empirical Observations on Risk, Return, and Market Structure

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

Activity of NXL104 in Combination with β-Lactams against Genetically Characterized Escherichia coli and Klebsiella pneumoniae Isolates Producing Class A Extended-Spectrum β-Lactamases and Class C β-Lactamases

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

Unbounded randomness certification using sequences of measurements

A formalism for steering with local quantum measurements

On characterising assemblages in Einstein–Podolsky–Rosen scenarios

Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013)

In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)

In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

Which breast pump for which mother: an evidence-based approach to individualizing breast pump technology

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011

Crop genetic erosion: understanding and responding to loss of crop diversity

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia

Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006

Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008–2009)

Suchergebnisse filtern